TipRanks
AFT Pharmaceuticals Ltd. (AU:AFP)
ASX:AFP
Australian Market

AFT Pharmaceuticals Ltd. (AFP) Income Statement

6 Followers

AFT Pharmaceuticals Ltd. Income Statement

Last quarter (Q4 2026), AFT Pharmaceuticals Ltd.'s total revenue was $139.76M, an increase of 25.01% from the same quarter last year. In Q4, AFT Pharmaceuticals Ltd.'s net income was $11.43M. See AFT Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
$ 254.71M$ 205.49M$ 195.41M$ 155.82M$ 129.83M
Gross Profit
$ 110.55M$ 89.19M$ 88.27M$ 72.16M$ 61.30M
Operating Expenses
$ 85.70M$ 77.49M$ 66.58M$ 55.04M$ 41.61M
Depreciation and Amortization
$ 3.70M$ 2.67M$ 2.01M$ 1.72M$ 1.04M
EBITDA
$ 28.55M$ 21.52M$ 27.72M$ 20.40M$ 21.12M
Operating Income
$ 24.86M$ 11.70M$ 24.23M$ 18.67M$ 20.08M
Other Income/Expenses
$ -2.98M$ 4.33M$ -2.22M$ -1.32M$ -1.70M
Pretax Income
$ 21.87M$ 16.03M$ 22.02M$ 15.80M$ 18.68M
Net Income
$ 14.73M$ 11.96M$ 15.61M$ 10.65M$ 19.85M
Per Share Metrics
Basic EPS
$ 0.14$ 0.11$ 0.15$ 0.10$ 0.19
Diluted EPS
$ 0.14$ 0.11$ 0.15$ 0.10$ 0.19
Weighted Average Shares Outstanding
104.87M 104.87M 104.87M 104.85M 104.68M
Weighted Average Shares Outstanding (Diluted)
104.87M 104.87M 104.87M 104.85M 104.68M
Currency in NZD

AFT Pharmaceuticals Ltd. Earnings and Revenue History